We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TTWO:NASDAQTake-Two Interactive Software, Inc. Analysis

Data as of 2026-09-06 - not real-time

$214.69

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

At $214.69, Take-Two Interactive Software, Inc. shows no decisive moving-average alignment, leaving the trend neutral. It has lost 7.3% over the past 30 days. RSI sits at 31.3, which reads as approaching oversold, and MACD momentum is bearish. Watch $211.33 as support and $256.62 as the nearer resistance level.
Valuation screens as fair: a P/E of 20.8 sits above the sector average of 15.5. Consensus targets land 33.6% above where the shares trade now. Revenue is growing at 2.0% on a -4.8% profit margin.
Risk scores 4 out of 10, which is moderate for this asset class. With 30-day volatility of 38.4%, a beta of 0.69 and a maximum drawdown of 27.7%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Short, medium and long-term reads agree on sell, with conviction of 5/10.

Top Market Events

Take-Two beats Q1 guidance with $1.39B in net bookings, reiterates fiscal 2027 outlook amid unprecedented GTA VI...After a strong three year run where Take-Two Interactive Software has returned 75.Yahoo Finance18dTake Two Interactive Software TTWO Could Be 13% Undervalued As Earnings And Guidance LandThe above...

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 5/10

Key Factors

  • Trading below the 200-day average of 227.89
  • MACD momentum is negative
  • 30-day price change of -7.3%

Medium Term

1–3 years
Cautious
Model confidence: 5/10

Key Factors

  • P/E of 20.8 versus sector average of 15.5
  • Trading below the 200-day average of 227.89
  • Analyst targets imply +33.6% versus the current price

Long Term

> 3 years
Cautious
Model confidence: 5/10

Key Factors

  • P/E of 20.8 versus sector average of 15.5
  • Negative profit margin of -4.8%
  • Analyst targets imply +33.6% versus the current price

Key Metrics & Analysis

Financial Health

Revenue Growth2.00%
Profit Margin-4.79%
P/E Ratio20.8
ROE-9.04%
ROA-0.62%
Debt/Equity81.61
P/B Ratio11.3
Op. Cash Flow$500.2M
Free Cash Flow$1.3B
Industry P/E15.5

Technical Analysis

TrendNeutral
RSI31.3
Support$211.33
Resistance$256.62
MA 20$234.32
MA 50$239.67
MA 200$227.89
MACDBearish
VolumeIncreasing
Fear & Greed Index95.48

Valuation

Fair Value$86.73
Target Price$286.89
Upside/Downside33.63%
GradeFair
TypeBlend

Risk Assessment

Beta0.69
Volatility38.37%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.